Navigation Links
Acc in Medical News

Siemens Demonstrates Workflow Efficiency in Echocardiography at ACC 2009

Instantaneous full-volume imaging and knowledge-based workflow applications streamline exam processes ORLANDO, Fla., March 28 /PRNewswire-FirstCall/ -- During the 58th Annual Scientific Session of the American College of Cardiology (ACC) from March 29-31 in Orlando, Fla., Siemens Healthcare ...

Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009

Siemens portfolio of cardiology applications covers the entire spectrum - from medical imaging, laboratory diagnostics, IT and customized support offerings ORLANDO, Fla., March 27 /PRNewswire/ -- Siemens Healthcare ( www.usa.siemens.com/healthcare ) demonstrates its commitment to excelle...

Siemens Demonstrates Flash Speed, Lowest Dose at ACC 2009

SOMATOM Definition Flash sets the bar higher for cardiology ORLANDO, Fla., March 26 /PRNewswire-FirstCall/ -- Siemens Healthcare ( www.usa.siemens.com/healthcare ) demonstrates the fastest speed and lowest dose for cardiac applications with the SOMATOM (R) Definition Flash dual source com...

Boston Scientific Announces Schedule For ACC 2009

NATICK, Mass., March 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the schedule of the Company's major events and news announcements at the 58th Annual Scientific Session of the American College of Cardiology / i2 Summit, which runs from March 28-31 in O...

Siemens Highlights Its Ultimate Hybrid System at ACC 2009

Artis zee family brings a broad range of imaging solutions to cardiology ORLANDO, Fla., March 25 /PRNewswire-FirstCall/ -- Siemens Healthcare ( www.usa.siemens.com/healthcare ) provides imaging excellence and workflow enhancements for cardiology with its ultimate hybrid at the 58th Annual ...

Siemens Highlights Cardiac-Specific C-Reactive Protein (hsCRP) Test at ACC 2009

hsCRP test used in JUPITER trial extended across portfolio ORLANDO, Fla., March 24 /PRNewswire/ -- According to a guidance document issued by the FDA(1), not all high sensitivity CRP (c-reactive protein) tests are cleared to identify and assess individuals at risk for future cardiovascular...

Siemens Demonstrates New Version of Multimodality Cardiology Image Management Solution at ACC 2008

Siemens Showcases Integrated Approach to Cardiovascular Image and Information Management CHICAGO, March 31 /PRNewswire-FirstCall/ -- Siemens Healthcare (http://www.siemens.com/healthcare ) will demonstrate the enhanced capabilities of the latest version of its syngo...

Experts from Penn's School of Medicine to present at ACC Annual Scientific Session

Penn experts will present research findings that could come to define new standards of cardiovascular diagnostics and care at this weekends conference of the American College of Cardiology, the foremost professional society representing heart specialists throughout the world. These experts will ga...

SCAI and ACC announce new interventional cardiology meeting

(September 10, 2007 -- WASHINGTON, DC) The Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) announced today that they will hold a unified interventional cardiology meeting in Chicago, March 29April 1, 2008. The meeting will be known as T...

See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC

New Artis zee Family Provides Interventional Cardiologists with Enhanced Imaging for Faster, More Precise Procedures CHICAGO, March 31 /PRNewswire-FirstCall/ -- According to the American Heart Association, cardiovascular disease ranks as America's No. 1 killer, with an average of ...

More>>

Acc in Medical Technology

RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009

FRANKLIN, Mass., March 27 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the first data from its pilot safety trial for RenalGuard(R) will be presented in a poster ...

Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session

SAN MATEO¿ Calif.¿ March 23 /PRNewswire/ -- Results from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at 10:30 a.m. EDT on Sunday, March 29, at the American College of Cardiology's (ACC...

Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions

Results of Mouse Model of Diabetes with Haptoglobin 2-2 Genotype Show Modification of HDL Structure and Defective Reverse Cholesterol Transport MONTVALE, N.J., March 31 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI ) announces data from a study of diabetic mice with the H...

Media Advisory: ACC Updated Schedule

Schering-Plough Announces Presentation Of Phase II Trial Results For Novel Oral Thrombin Receptor Antagonist At The 2007 Annual Meeting Of The American College Of Cardiology/i2 Summit KENILWORTH, N.J., March 16, 2007 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that result...

Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2 Predicts Heart Disease Risk in Metabolic Syndrome Patients

NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Study results show that elevated lipoprotein-associated phospholipase A2 (Lp-PLA2), a cardiovascular-specific inflammatory enzyme associated with unstable plaque that can lead to heart attack and stroke, is especially predictive of heart disease risk in ...

Study Presented at ACC Shows Treatment With ISIS 301012 Added to Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C Levels of Less Than 70 mg/dL

* ISIS 301012 coadministered with statins for only five weeks at 400 mg/week lowered LDL-C 47% beyond the levels achieved with statins alone, with similarly favorable effects on other atherogenic lipids NEW ORLEANS and CARLSBAD, Calif., March 26, 2007 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals...

Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical Data for INO-1001 at ACC Demonstrating PARP Inhibition and Anti-inflammatory Activity in Plasma of Patients Undergoing Primary Percutaneous Coronary Intervention

BEVERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek Pharmaceuticals Corporation announced today the presentation of positive Phase 2 clinical data demonstrating the safety of INO-1001 as well as the potential for INO-1001 as a preventative agent for cardiac reperfusion injury. The study was cond...

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC

* Homozygous FH patients already being treated with maximally tolerated lipid-lowering therapies experienced 50% further reductions in LDL-C with similar reductions in other atherogenic when treated with 300 mg/week ISIS 301012 NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007 /PRNewswire-FirstCal...

New Bisphenol A Study Is of Very Limited Relevance to Human Health

...g companies engaged in the business of chemistry. acc members apply the science of chemistry to make inn... make people's lives better, healthier and safer. acc is committed to improved environmental, health and... and security have always been primary concerns of acc members, and they have intensified their efforts, ...

Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure

...sented at Late-Breaking Clinical Trials Session at acc 58th Annual Scientific Session; Results Published ...y results presented in this important forum at the acc and published in the prestigious journal The Lance... 858.717.2310 (mobile number while at acc Scientific Session) david.schull@...

More>>

Acc in Biological News

LDL particle measurement by NMR recognized by ADA, ACC

Raleigh, NC, March 28, 2008 - The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number by nuclear magnetic resonance (NMR) is one of the more accurate ways to evaluate cardiometabolic ...

Sustainable agriculture at the ESA Annual Meeting

...y, and Biofuels I. Tuesday, Aug. 4, 3:40 p.m., Taos room, ACC Shashi Kumar: PS 42 - Agricultural Landscapes. Wed., Aug. 5, 5-6:30 p.m., Exhibit Hall, acc ...

Millisecond brain signals predict response to fast-acting antidepressant

...CC), signals a better response. To find out if acc activity might also forecast response to glutamate...n to activate the ACC. While healthy participants' acc activity dropped off as they quickly habituated to the faces, patients' acc activity showed an opposite trend. The more robust...

Cardiologists and heart surgeons meet for 'Controversies and Advances' conference

...thoracic Surgery at Cedars-Sinai; and John G. Harold, M.D., FACC, cardiologist and President, California Chapter American College of Cardiology (ACC), acc Governor for Southern California, and a recent Chief of Staff at Cedars-Sinai. Sessions on Thursday, Oct. 4, will address coronary artery disease (...

Smoking changes brain chemistry

...ne pack year), the lower the NAA level. "The acc is involved in mediating conditioned reinforcement...ol dependence. Choline concentrations in the acc were slightly lower in the smokers compared with t.... Gür said. "The degree of reduction of NAA in the acc depends on the amount of tobacco consumed over tim...

Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet

...rts to burn fat while simultaneously shutting down acc through a chemical modification called phosphoryla...B3 serves as a go-between for an enzyme that marks acc for degradation," says Jose Heredia, a graduate st...pose tissue usually rise only during fasting, when acc should be turned off. Heredia and co-first author ...

More>>

Acc in Biological Technology

Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

- First Stem Cell Trial to Show Dose-related Significant Improvement in Perfusion - ORLANDO, Fla., March 30 /PRNewswire/ -- Amorcyte, Inc. (Amorcyte) today announced data from its Phase I clinical trial of AMR-001, the company's lead product for the treatment of damaged heart muscle fol...

Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients

LDL, Non-HDL and apoB measurement helps physicians guide therapy for cardiometabolic risk patients BIRMINGHAM, Ala., April 22 /PRNewswire/ -- The determination of LDL, non-HDL and apoB are now recognized as valid, accurate and recommended methods of guiding and achieving ...

Boston Scientific Announces Schedule for ACC 2008

NATICK, Mass., March 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the schedule of the Company's major events and news announcements at the Society for Cardiovascular Angiography and Interventions SCAI Annual Scientific Sessions in Partnership with th...

Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago

DENVER, March 20 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced it will be exhibiting its AspirinWorks(R) Test at the American College of Cardiology (ACC) 57th Annual Scientific Sessio...

Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago

VAP expanded cholesterol test can help clinicians identify best treatment options for patients at risk of heart disease BIRMINGHAM, Ala., March 7 /PRNewswire/ -- Atherotech, Inc., a cardio-diagnostic company, today announced it will be exhibiting its VAP Cholesterol Test(R) in Booth...

Resverlogix Provides Quarterly Update

...recent Wall Street Journal article," stated McCaffrey. At the most recent acc conference held in Orlando Florida RVX-208 was the subject of two key plena...s and cardiovascular disease. In a second keynote address during the same acc conference Dr. Prediman K. Shah, Director of the Division of Cardiology and...

New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando

...y 1) inaccurate individualized assessment of cardiovascular risk and 2) inadequate monitoring of vascular response to treatments. Note: During the acc 2009, Endothelix will hold a "Drink & Draw" event at Rosen Plaza Hotel Backstage Club where a lucky person will win the VENDYS round-tri...

Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship

...d capability and adaptability Sage Intergy offers, acc will be able to: -- Capture the data nece...ollowed by calls from debt collectors. This allows acc to work in a cooperative manner with patients to i...l its clinical trials into the EHR alert function, acc will be able to identify candidates for clinical t...

Anthera Presents Data on Varespladib at ATVB Meeting

...im Trias, Ph.D., Senior Vice President of Preclinical Development at Anthera Pharmaceuticals, Inc. "Along with the Phase II PLASMA data presented at acc earlier this year, today's announcement gives us added confidence as we move the Varespladib clinical program forward," said Dr. James E. Pennington, ...

Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over

...in Chicago on Monday 31 March at 10.00 CDT / 16.00 BST. Details of how to dial in and/or watch live streaming of the briefing can be obtained from the acc Press Office For further information please contact: Laura Gallagher Senior Press Officer Imperial College London e-mail: L.Gallagher@imperi...

More>>

Acc in Biological Definition

Amino acid

... is found together with unsaturated amino acids in lantibiotics (antibiotic peptides of microbial origin). 1-Aminocyclopropane-1-carboxylic acid ( acc ) is a small disubstituted cyclic amino acid and a key intermediate in the production of the plant hormone ethylene . In addition to amino acids ...
Other Tags
(Date:12/24/2014)... Oregon (PRWEB) December 24, 2014 ... Rehab sat down with Derek Fenwick, PT, MBA, ... changes that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, ... title XVIII of the Social Security Act to standardize ...
(Date:12/24/2014)... -- A new, injectable weight-loss drug has been approved ... agency on Tuesday approved Saxenda (liraglutide) for adults who ... have at least one weight-related health condition, such as ... Patients taking the drug, made by Novo Nordisk, ... the FDA noted. "Obesity is a public health ...
(Date:12/24/2014)... Steven Reinberg HealthDay Reporter ... the American Diabetes Association (ADA) call for giving the cholesterol-lowering ... help prevent heart disease. These new standards bring the ... American Heart Association, which also recommend giving low- or high-dose ... people with diabetes. "We agree that the decision to ...
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 24, 2014 ... COC Industry is a professional and in-depth research ... the report introduces COC basic information, including its ... policy analysis, news analysis, etc. This report also ... structure etc. Production is separated by regions, technology ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Dental implants ... for a tooth replacement. They offer the strongest and ... advantages over other forms of tooth replacement. They will ... on the adjacent teeth for support, and they prevent ... have been told that they are not suitable candidates ...
Breaking Medicine News(10 mins):Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the ... a study that pinpoints fine-scale differences in genetic ancestry ... . Since immigrants first arrived more ... States has served as a meeting place ... American history and the ongoing mixing of peoples with ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
Other Contents